GUFIC BIOSCIENCES
GUFICBIOVerifiedGUFIC BIOSCIENCES is a publicly traded security listed on the NSE/BSE exchange.
Stock Snapshot & Key Numbers — GUFIC BIOSCIENCES
Verified Daily CloseOfficial closing price, 1-year price range, valuation multiples, and market value from exchange records.
GUFIC BIOSCIENCES (GUFICBIO) is a Indian equity security listed on the NSE/BSE with ISIN BSE:509079. As of the last recorded market session on Close on 16 Oct 2026, the stock closed at ₹404.50, recording a -3.95 (-0.97%) decline from its previous close of ₹408.45. Over the trailing 52-week trading cycle, GUFICBIO has traded between a 52-week low of ₹273.50 and a 52-week high of ₹448.00, establishing its annual trading channel. In historical performance, GUFIC BIOSCIENCES has gained 13.86% over the past 1 year. Period returns across standard measurement intervals include: 1-week: -0.44%, 1-month: -3.66%, 6-month: +33.74%, 1-year: +13.86%, 3-year: +46.45%, 5-year: +108.24%. Daily reported trading volume reached 29,583 equity shares. On key valuation multiples as of 11 Oct 2026, the company trades at a trailing price-to-earnings (P/E) multiple of 55.5x and a price-to-book (P/B) ratio of 6.1x, with a trailing dividend yield of 0.02%. Its market capitalization stands at ₹4,074.48 Cr. The company is categorized under the Diversified Indian Equities sector and Public Market Listed Security industry within the Indian equities universe.
Price Chart
Trading Multiples & Ranges
Price boundaries and liquidity distribution.
Past Price Win/Loss Odds (1-Week, 1-Month, 3-Month)
How often this stock rose, stayed flat, or fell over past 21-day holding periods (based on historical data, not a future prediction).
How Outside Factors Affect This Stock (Market, Crude Oil & Currency)
How closely this stock moved with the broader market index, crude oil, and the exchange rate over the past year.
| Factor / Benchmark | 1Y Beta (Sensitivity) | 1Y Correlation (-1 to +1) | What This Means |
|---|---|---|---|
| NIFTY 50 | +0.67 | +0.26 | Trailing 1Y historical sensitivity: a 1% move in NIFTY 50 coincided with a +0.67% co-movement (correlation: 0.26). Descriptive historical relationship, not predictive. |
| USD / INR | -0.34 | -0.07 | Trailing 1Y historical sensitivity: a 1% move in USD / INR coincided with a -0.34% co-movement (correlation: -0.07). Descriptive historical relationship, not predictive. |
| Brent Crude Oil | -0.12 | -0.19 | Trailing 1Y historical sensitivity: a 1% move in Brent Crude Oil coincided with a -0.12% co-movement (correlation: -0.19). Descriptive historical relationship, not predictive. |
| US 10Y Treasury Yield | -0.22 | -0.09 | Trailing 1Y historical sensitivity: a 1% move in US 10Y Treasury Yield coincided with a -0.22% co-movement (correlation: -0.09). Descriptive historical relationship, not predictive. |
How to read Beta & Correlation ( Beta > 1 = wider swings than market; < 1 = calmer )▾
Sensitivities measure historical 1-year regression beta and correlation across paired daily trading sessions over the past 252 trading days. Past relationships can shift over time and do not guarantee future co-movement.
Trailing Returns Breakdown
Calendar-aligned historical percentage performance across standard market windows.
| Period | Start Price | Current Price | Return (%) |
|---|---|---|---|
| 1 Week | ₹406.30 | ₹404.50 | -0.44% |
| 15 Days | ₹418.40 | ₹404.50 | -3.32% |
| 1 Month | ₹419.85 | ₹404.50 | -3.66% |
| 3 Months | ₹388.30 | ₹404.50 | +4.17% |
| 6 Months | ₹302.45 | ₹404.50 | +33.74% |
| 1 Year | ₹355.25 | ₹404.50 | +13.86% |
| 3 Years | ₹276.20 | ₹404.50 | +46.45% |
| 5 Years | ₹194.25 | ₹404.50 | +108.24% |
Price Swings & Biggest Historical Drops
How much this stock typically fluctuates and its largest peak-to-bottom drops over 1 and 5 years.
Calendar-Year Historical Performance
Annual performance breakdown comparing first and last closing sessions of each calendar year.
| Calendar Year | Start Close | End Close | Annual Return | Trajectory Bar |
|---|---|---|---|---|
| CY 2026 | ₹341.40 | ₹404.50 | +18.5% | |
| CY 2025 | ₹456.55 | ₹336.00 | -26.4% | |
| CY 2024 | ₹314.55 | ₹455.30 | +44.8% | |
| CY 2023 | ₹228.85 | ₹316.45 | +38.3% | |
| CY 2022 | ₹244.45 | ₹226.45 | -7.4% | |
| CY 2021 | ₹194.25 | ₹237.60 | +22.3% |
Historical Investment Simulator
Factual simulation of past returns in GUFIC BIOSCIENCES (GUFICBIO) using real recorded closing prices.
Corporate Actions & Distributions
Historical record of dividend payouts and share split adjustments for GUFICBIO.
Dividend Distributions (1)
| Ex-Date | Dividend Amount |
|---|---|
| 28 Aug 2026 | ₹0.10 per share |
Stock Splits & Multipliers (0)
No stock split adjustments recorded.
Recent News & Official Exchange Announcements
Official exchange filings, order wins, and company updates. Click any announcement to see how it affects the business on the right.
Gufic Biosciences Ltd (BOM:509079) Q4 2026 Earnings Call Highlights: Record Revenue and ... - Yahoo Finance
Gufic Biosciences Ltd (BOM:509079) Q4 2026 Earnings Call Highlights: Record Revenue and ... Yahoo Finance
Gufic Biosciences Targets 15% Revenue Growth and 20% EBITDA Margin by 2030 - Sahi
Gufic Biosciences Targets 15% Revenue Growth and 20% EBITDA Margin by 2030 Sahi
Gufic BioSciences wins appeal against ₹4.33 crore tax demand - scanx.trade
Gufic BioSciences wins appeal against ₹4.33 crore tax demand scanx.trade
Gufic Biosciences to pay ₹1.72 lakh NSE penalty after waiver rejection - scanx.trade
Gufic Biosciences to pay ₹1.72 lakh NSE penalty after waiver rejection scanx.trade
Gufic Biosciences NSE Penalty Waiver Rejected September 2026 - Kalkine India
Gufic Biosciences NSE Penalty Waiver Rejected September 2026 Kalkine India
Why This Matters for the Business
Plain-English breakdown of how the selected announcement connects to revenue, costs, and business drivers.
Financial performance outpaced historical baseline, driving operating leverage and valuation re-rating.
- •Financial performance and operating margins expanded ahead of consensus projections
Volume throughput absorbs fixed manufacturing plant overheads, supporting operating EBITDA margins and cash generation across diversified indian equities units.
Continuous commercial tenders and capital expenditures lock in forward order book-to-bill expansion.
At-a-Glance Health & Momentum Check
Recent exchange filings and reported financial statements show healthy alignment between revenue growth, operating cash flow, and improving profit margins.
Peer & Sector Comparison — Next Research Steps
Exit points and comparative equity universe: same-sector peers, shared macro sensitivity betas, and your watchlist.
Common Questions About GUFIC BIOSCIENCES (GUFICBIO)
Key facts on GUFICBIO share price, historical returns, valuation ratios, and past SIP performance.
What is the current share price and 52-week range of GUFIC BIOSCIENCES (GUFICBIO)?
As of 16 Oct 2026, the official closing share price of GUFIC BIOSCIENCES (GUFICBIO) on NSE/BSE is ₹404.50 (-0.97% vs the previous close). Over the past 52 weeks, GUFICBIO has traded between a low of ₹273.50 and a high of ₹448.00, with a reported market capitalization of ₹4,074.48 Cr.
What are the historical returns of GUFIC BIOSCIENCES (GUFICBIO)?
Based on split-adjusted closing prices through 16 Oct 2026, GUFIC BIOSCIENCES (GUFICBIO) recorded the following trailing price returns: 1 Week: -0.44% (from ₹406.30 to ₹404.50); 15 Days: -3.32% (from ₹418.40 to ₹404.50); 1 Month: -3.66% (from ₹419.85 to ₹404.50); 3 Months: +4.17% (from ₹388.30 to ₹404.50); 6 Months: +33.74% (from ₹302.45 to ₹404.50); 1 Year: +13.86% (from ₹355.25 to ₹404.50); 3 Years: +46.45% (from ₹276.20 to ₹404.50); 5 Years: +108.24% (from ₹194.25 to ₹404.50). Past performance reflects historical exchange records and does not predict future returns.
What is the P/E ratio, P/B ratio, and dividend yield of GUFIC BIOSCIENCES (GUFICBIO)?
GUFIC BIOSCIENCES (GUFICBIO) currently trades at a trailing Price-to-Earnings (P/E) ratio of 55.5x, a Price-to-Book (P/B) ratio of 6.1x, and a trailing 12-month dividend yield of 0.02%. It operates in the Diversified Indian Equities sector (Public Market Listed Security).
How much would a past lump-sum or monthly SIP investment in GUFICBIO have grown?
Based on historical closing prices for GUFIC BIOSCIENCES (GUFICBIO): A one-time lump-sum investment of ₹1,00,000.00 held for 5 years would be worth ₹2,08,236.81 (+108.2% total return, 15.8% CAGR), while a monthly SIP of ₹10,000.00 over 5 years (total invested: ₹6,10,000.00) would be worth ₹8,72,747.36 (+43.1% absolute return). You can test custom amounts and holding periods in the interactive calculator above.
Official Corporate Perspective
Authorized Investor Relations officers may submit authenticated context or coordinate with our research team.